Factors associated with medicine use among children aged under 12 years--a population survey in Finland

Pharmacoepidemiology and Drug Safety
Katri Hämeen-AnttilaRiitta Ahonen

Abstract

The goal was to determine the prevalence of medicine use and to provide population-based information on factors associated with medicine use, including prescribed and over-the-counter (OTC) medicines, in children aged under 12 years. A cross-sectional population survey of a random sample of children aged under 12 years (n = 6000) was carried out in Finland in spring 2007, with a response rate of 67%. A questionnaire was sent to their parents. Current use of medicines prescribed by a physician and use of OTC medicines during the preceding two days were the main outcome measures. The prevalence of current prescribed medicine use was 17%, and the 2-day prevalence of OTC medicine use 17% (vitamins excluded). The use of prescribed medicines was higher among children with illnesses diagnosed by a physician. Additionally, predictors for the use of prescribed medicines were young age among boys, health status worse than good, and the use of any prescribed medicines by a parent. The predictors for the use of OTC medicines by the child were young age and fairly good to poor health status, and the use of OTC medicines by a parent. However, children with any illnesses diagnosed by a physician were less likely to use OTC medicines. A consid...Continue Reading

References

Sep 23, 1985·Proceedings of the Royal Society of London. Series B, Containing Papers of a Biological Character·T Takahashi
Jan 1, 1986·Social Science & Medicine·L A MaimanA W Katlic
Oct 5, 1994·JAMA : the Journal of the American Medical Association·M D KoganM Kotelchuck
Dec 1, 1996·Journal of Public Health Medicine·R Dengler, H Roberts
May 1, 1997·Archives of Pediatrics & Adolescent Medicine·C T ChambersG A Finley
Sep 1, 2000·European Journal of Pediatrics·S StoelbenW Kirch
Jun 22, 2001·European Journal of Clinical Pharmacology·H MadsenJ Hallas
Jan 5, 2002·European Journal of Clinical Pharmacology·T CazzatoUNKNOWN ACP Puglia-Basilicata Working Group
Mar 18, 2003·The Annals of Pharmacotherapy·Ebba H HansenCandace E Currie
Oct 14, 2003·Scandinavian Journal of Public Health·Bjørn E HolsteinAnna Birna Almarsdóttir
Oct 31, 2003·Pharmacy World & Science : PWS·Hilde TobiLolkje T de Jong-van den Berg
Nov 22, 2005·Acta Paediatrica·Carlo GagliottiMaria Luisa Moro
Jan 1, 1985·Journal of Pharmaceutical and Biomedical Analysis·J C BerridgeR V Platt
Dec 1, 2006·Journal of Andrology·Jin-Chun LuNian-Qing Lu

❮ Previous
Next ❯

Citations

Oct 25, 2012·European Journal of Clinical Pharmacology·L Lindell-OsuagwuK Vainio
Jun 11, 2011·BMC Public Health·Sanna M SiponenKatri P Hämeen-Anttila
Nov 8, 2011·BMC Complementary and Alternative Medicine·Katri P Hämeen-AnttilaRiitta S Ahonen
Aug 17, 2010·Pharmacoepidemiology and Drug Safety·Sanna YlinenRiitta Ahonen
Feb 16, 2013·Journal of Community Health·Huy Van NguyenJoseph Debattista
Jan 22, 2011·Pharmacoepidemiology and Drug Safety·Reeta HeikkiläRiitta Ahonen
Jul 7, 2015·Pharmacoepidemiology and Drug Safety·Salvatore ItaliaSilke Britta Wolfenstetter
Nov 22, 2018·Revista paulista de pediatria : orgão oficial da Sociedade de Pediatria de São Paulo·Hellen Karoline ManieroDayani Galato
Aug 23, 2011·International Journal of Clinical Pharmacy·Katri Hämeen-AnttilaRiitta Ahonen
Jan 8, 2014·Pediatrics·Janne Fangel JensenLisbeth Ehlert Knudsen
Mar 3, 2012·Research in Social & Administrative Pharmacy : RSAP·Miina HolappaKatri Hämeen-Anttila

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.